The increasing interest in potent weight management has spurred considerable exploration into cutting-edge treatments. Recently , Retatrutide, a dual -action glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor stimulator, has exhibited encouraging results in patient trials, impl